Q32 Bio Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Q32 Bio Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Q32 Bio Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $221M, a 23.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $221M +$41.7M +23.2% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $180M +$16.3M +9.95% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $163M +$38.4M +30.7% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $125M +$47.2M +60.7% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $77.8M +$40.2M +107% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $37.6M +$25.1M +201% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $12.5M Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.